Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berkowitz

Showing results (371-380 of 497) with videos related to

Pageof 50
Sort By:
The American Journal of Cardiology|March 23, 2000
Efficacy of abciximab readministration in coronary interventionM Madan, D J Kereiakes, J B Hermiller, et al.
Journal of Pain Research|December 10, 2019
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid TherapySergio D Bergese, Marek Brzezinski, Gregory B Hammer, et al.
Journal of Pain & Palliative Care Pharmacotherapy|July 19, 2021
Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-StudyRichard D Berkowitz, Richard Steinfeld, Alexander P Sah, et al.
JAMA Cardiology|September 30, 2020
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical TrialEric Kaplovitch, John W Eikelboom, Leanne Dyal, et al.
Circulation|October 18, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PADJennifer Rymer, Sonia S Anand, E Sebastian Debus, et al.
Clinical Therapeutics|April 14, 2025
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current EvidenceMario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, et al.
Journal of Cardiovascular Development and Disease|April 27, 2023
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future DirectionsMario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, et al.
World Journal for Pediatric & Congenital Heart Surgery|December 8, 2016
Membrane Oxygenator Use With Biventricular Assist Device: Facilitation of Support and Lung RecoveryKristen Nelson-McMillan, William J Ravekes, William R Thompson, et al.
JAMA|April 2, 2009
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interestDavid J Rothman, Walter J McDonald, Carol D Berkowitz, et al.
Thrombosis Journal|September 24, 2013
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesMartin H Prins, Anthonie Wa Lensing, Rupert Bauersachs, et al.
Pageof 50

Showing results (371-380 of 497) with videos related to

Sort By:
Pageof 50
The American Journal of Cardiology|March 23, 2000
Efficacy of abciximab readministration in coronary interventionM Madan, D J Kereiakes, J B Hermiller, et al.
Journal of Pain Research|December 10, 2019
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid TherapySergio D Bergese, Marek Brzezinski, Gregory B Hammer, et al.
Journal of Pain & Palliative Care Pharmacotherapy|July 19, 2021
Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-StudyRichard D Berkowitz, Richard Steinfeld, Alexander P Sah, et al.
JAMA Cardiology|September 30, 2020
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical TrialEric Kaplovitch, John W Eikelboom, Leanne Dyal, et al.
Circulation|October 18, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PADJennifer Rymer, Sonia S Anand, E Sebastian Debus, et al.
Clinical Therapeutics|April 14, 2025
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current EvidenceMario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, et al.
Journal of Cardiovascular Development and Disease|April 27, 2023
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future DirectionsMario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, et al.
World Journal for Pediatric & Congenital Heart Surgery|December 8, 2016
Membrane Oxygenator Use With Biventricular Assist Device: Facilitation of Support and Lung RecoveryKristen Nelson-McMillan, William J Ravekes, William R Thompson, et al.
JAMA|April 2, 2009
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interestDavid J Rothman, Walter J McDonald, Carol D Berkowitz, et al.
Thrombosis Journal|September 24, 2013
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesMartin H Prins, Anthonie Wa Lensing, Rupert Bauersachs, et al.
Pageof 50